'Adverse events' presentation slideshows

Adverse events - PowerPoint PPT Presentation


Journal Club

Journal Club

Journal Club. Francesco D’Aiuto , Nikolaos Gkranias , Devina Bhowruth , Tauseef Khan, Marco Orlandi , Jean Suvan , Stefano Masi , Georgios Tsakos , Steve Hurel , Aroon D Hingorani , Nikos Donos *, John E Deanfield *, for the TASTE Group†

By adamdaniel
(265 views)

ASA III and IV patients in the surgical day care centre: feasible?

ASA III and IV patients in the surgical day care centre: feasible?

ASA III and IV patients in the surgical day care centre: feasible?. Dr Bosmans Dr Teunkens. ASA III. Patiënt met een ernstige systemische aandoening die niet-levensbedreigend is, maar zijn normale activiteiten zijn beperkt

By Samuel
(308 views)

Driver Diagrams

Driver Diagrams

Driver Diagrams. Jackie McCallum. Why use driver diagrams?. To break any broad aim, graphically, into increasing levels of detailed actions that must or could be done to achieve the stated aim. What do driver diagrams do?. Encourages team to expand their thinking

By lotus
(995 views)

Comparison of INSTI vs PI

Comparison of INSTI vs PI

Comparison of INSTI vs PI. FLAMINGO GS-236-0103 ACTG A5257. FLAMINGO Study : DTG QD + 2 NRTI vs DRV/r QD + 2 NRTI. Design. Randomisation* 1 : 1 Open-label. W48. W96. > 18 years ARV-naïve HIV RNA > 1,000 c/mL Any CD4 cell count No primary resistance in RT or protease. N = 243.

By paul
(197 views)

Serious Reportable Events 2018

Serious Reportable Events 2018

Serious Reportable Events 2018. June 12, 2019 Public Health Council. Katherine T. Fillo , Ph.D., MPH, RN-BC Katherine Saunders, MS Bureau of Health Care Safety and Quality Bureau of Health Care Safety and Quality. Overview. Purpose Background

By Mercy
(578 views)

Preventing the Use of Incorrect Dialysate or Dialyzer

Preventing the Use of Incorrect Dialysate or Dialyzer

Preventing the Use of Incorrect Dialysate or Dialyzer. Is Key to Keeping Kidney Patients Safe. Incorrect Dialysate or Dialyzer. Setting up the wrong dialyzer or dialysate for a patient can be a dangerous event that can result in harm to patients.

By essien
(1443 views)

Meet The Professors Hodgkin Lymphoma 2018

Meet The Professors Hodgkin Lymphoma 2018

Meet The Professors Hodgkin Lymphoma 2018. Hodgkin Lymphoma (HL) by the Numbers. Optimal Upfront Treatment 8700 pts. 700 Pts ≥70 years No standard TX. Favorable ES. Unfavorable ES. Unfavorable ES with Bulk. Favorable AS. Unfavorable AS. 1000. 2500. 1000. 2500. 1000. 100 Fail.

By ozzie
(411 views)

Treatment principles

Treatment principles

Treatment principles. Schizophrenia. The progression of schizophrenia and functional decline. Premorbid. Prodromal. Progression/ clinical deterioration. Chronic residual. Healthy. Illness-driven decline in functioning plateaus.

By abram
(1132 views)

Tuberculosis in Children: Treatment and Monitoring

Tuberculosis in Children: Treatment and Monitoring

Module 10B - March 2010. Tuberculosis in Children: Treatment and Monitoring. Project Partners. Funded by the Health Resources and Services Administration (HRSA). Module Overview. Treating childhood TB Monitoring the pediatric patient on TB treatment. Learning Objective.

By sylvia
(186 views)

Case Presentation

Case Presentation

Case Presentation. 25 yo g2p1 at 41 weeks Induction scheduled and begun Long and slow, AROM finally That night, at home… What went wrong? How can this be avoided in the future?. Patient Safety and Human Factors Engineering. LTC Gary W. Clark, MD MPH. Define: Error Define: Patient Safety.

By cais
(190 views)

Contract Negotiation Process

Contract Negotiation Process

Contract Negotiation Process. Janene Peterson Shelton, CDAs Angelyn Griffing, CTAs Karen Myers, Subawards & Incoming Contracts. Overview. Handouts Contracts Organization Chart Contract Definition Contract Conformity Confidential Disclosure Agreements Clinical Trial Agreements

By afya
(447 views)

Maternal clinical considerations

Maternal clinical considerations

1. Maternal clinical considerations. IMPAACT 2010 study-specific Training May 2017. 2. Overview. Medical and Medication Histories Standardized Questionnaires (role play) Physical Examinations Laboratory Evaluations Source Documentation and eCRF Requirements.

By ann
(418 views)

Medical Errors: Avoiding Further Harm to Patients and Clinicians

Medical Errors: Avoiding Further Harm to Patients and Clinicians

Medical Errors: Avoiding Further Harm to Patients and Clinicians. Jo Shapiro, MD, FACS Director, Center for Professionalism and Peer Support Brigham and Women’s Hospital Associate Professor, Otolaryngology Harvard Medical School.

By milla
(460 views)

Promise #2 Improved Quality and Safety

Promise #2 Improved Quality and Safety

Promise #2 Improved Quality and Safety. Moderator Julie Creamer , Senior Vice President Quality and Planning Panel Carole Cotter , CIO Lifespan Steve Hasley, M.D. Director Clinical Interoperability Decision Support, UPMD Ed Marx, CIO Texas Health Resources

By markku
(520 views)

Suvaporn Anugulruengkitt , Piyarat Suntarattiwong , Pradthana Ounchanum ,

Suvaporn Anugulruengkitt , Piyarat Suntarattiwong , Pradthana Ounchanum ,

Safety and nevirapine concentrations of 6-week triple antiretroviral prophylaxis in high risk HIV-exposed infants. Suvaporn Anugulruengkitt , Piyarat Suntarattiwong , Pradthana Ounchanum , Ussanee Srirompotong , Watsamon Jantarabenjakul , Jiratchaya Sophonphan ,

By gracie
(94 views)

What is Deworming and Why Does India Have a National Deworming Day?

What is Deworming and Why Does India Have a National Deworming Day?

What is Deworming and Why Does India Have a National Deworming Day?. An overview for media personnel. What are worms and how do they harm children?. Worms are parasites that thrive on nutrition from the human intestine. An infected child contaminates soil with faeces containing worm

By lael
(114 views)

Methylphenidate Regulatory History Pediatric Advisory Committee Meeting June 30, 2005

Methylphenidate Regulatory History Pediatric Advisory Committee Meeting June 30, 2005

Methylphenidate Regulatory History Pediatric Advisory Committee Meeting June 30, 2005. Paul J. Andreason, M.D. Team Leader Division of Neurpharmacological Drug Products. Approved Medical Treatment Modalities. Stimulants Methylphenidate Products Amphetamine Products Pemoline Atomoxetine.

By temple
(222 views)

OVERTURE

OVERTURE

OVERTURE. Milton Packer, M.D., FACC Columbia University College of Physicians and Surgeons Columbia Presbyterian Medical Center New York, NY. FDA Cardiovascular and Renal Drugs Advisory Committee Meeting July 19, 2002. Question.

By blaine
(331 views)

DailyMed

DailyMed

DailyMed. Stuart J. Nelson, MD, FACP , FACMI National Library of Medicine National Institutes of Health. DailyMed. Structured Product Labels Searching by Names or Codes Publicly Available at No Cost Archive of Labels Online 24/7 . Other Features of DailyMed. Links PubMed MEDLINEplus

By cahil
(195 views)

May 2, 2019 12-1pm EST Dial-in: 888-672-1467

May 2, 2019 12-1pm EST Dial-in: 888-672-1467

May 2, 2019 12-1pm EST Dial-in: 888-672-1467. The Maryland SPARC Collaborative presents: Throwing (Pre)Caution(s) to the Wind: SPARCing a Debate on Stopping Contact Precautions. Contact precautions: What does the data really show?. Anthony Harris, MD, MPH MD, MPH Professor

By ewa
(4 views)

View Adverse events PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Adverse events PowerPoint presentations. You can view or download Adverse events presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.